{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:49:38Z","timestamp":1792525778246,"version":"4.5.0"},"reference-count":96,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/501100004564","name":"Ministry of Science, Republic of Serbia","doi-asserted-by":"publisher","award":["173033"],"award-info":[{"award-number":["173033"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Ministry of Science, Republic of Serbia","doi-asserted-by":"publisher","award":["173034"],"award-info":[{"award-number":["173034"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2019,5,28]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Insulin is essential for the treatment of Type 1 diabetes mellitus (T1DM) and is necessary in numerous cases of Type 2 diabetes mellitus (T2DM). Prolonged administration of anti-diabetic therapy is necessary for the maintenance of the normal glucose levels and thereby preventing vascular complications. A better understanding of the disease per se and the technological progress contribute to the development of new approaches with the aim to achieve better glycemic control.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>Current therapies for DM are faced with some challenges. The purpose of this review is to analyze in detail the current trends for insulin delivery systems for diabetes treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Contemporary ways have been proposed for the management of both types of diabetes by adequate application of drug via subcutaneous, buccal, oral, ocular, nasal, rectal and pulmonary ways. Development of improved oral administration of insulin is beneficial regarding mimicking physiological pathway of insulin and minimizing the discomfort of the patient. Various nanoparticle carriers for oral and other ways of insulin delivery are currently being developed. Engineered specific properties of nanoparticles (NP): controlling toxicity of NP, stability and drug release, can allow delivery of higher concentration of the drug to the desired location.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>The successful development of any drug delivery system relies on solving three important issues: toxicity of nanoparticles, stability of nanoparticles, and desired drug release rate at targeted sites. The main goals of future investigations are to improve the existing therapies by pharmacokinetic modifications, development of a fully automatized system to mimic insulin delivery by the pancreas and reduce invasiveness during admission.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1381612825666190306153838","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T11:33:12Z","timestamp":1552044792000},"page":"166-173","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Drug Delivery Systems for Diabetes Treatment"],"prefix":"10.2174","volume":"25","author":[{"given":"Bozidarka L.","family":"Zaric","sequence":"first","affiliation":[{"name":"Institute of Nuclear Sciences Vinca, University of Belgrade, Laboratory of Radiobiology and Molecular Genetics, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Obradovic","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Sciences Vinca, University of Belgrade, Laboratory of Radiobiology and Molecular Genetics, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emina","family":"Sudar-Milovanovic","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Sciences Vinca, University of Belgrade, Laboratory of Radiobiology and Molecular Genetics, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovan","family":"Nedeljkovic","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Sciences Vinca, University of Belgrade, Laboratory of Radiation Chemistry and Physics, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Lazic","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Sciences Vinca, University of Belgrade, Laboratory of Radiation Chemistry and Physics, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esma R.","family":"Isenovic","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Sciences Vinca, University of Belgrade, Laboratory of Radiobiology and Molecular Genetics, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"698","volume":"42","author":"Forouhi N.G.","year":"2014","unstructured":"Forouhi NG, Wareham NJ."},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.3109\/10717544.2014.991001","volume":"23","author":"Rai V.K.","year":"2016","unstructured":"Rai VK, Mishra N, Agrawal AK, Jain S, Yadav NP. Novel drug delivery system: an immense hope for diabetics.","journal-title":"Drug Deliv"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"314","DOI":"10.5603\/EP.2016.0044","volume":"67","author":"Cichocka E.","year":"2016","unstructured":"Cichocka E, Wietchy A, Nabrdalik K, Gumprecht J. Insulin therapy - new directions of research.","journal-title":"Endokrynol Pol"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/2230-973X.176456","volume":"6","author":"Shah R.B.","year":"2016","unstructured":"Shah RB, Patel M, Maahs DM, Shah VN. Insulin delivery methods: Past, present and future.","journal-title":"Int J Pharm Investig"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1089\/dia.2017.0012","volume":"19","author":"Castle J.R.","year":"2017","unstructured":"Castle JR, DeVries JH, Kovatchev B. Future of Automated Insulin Delivery Systems.","journal-title":"Diabetes Technol Ther"},{"key":"ref=6","author":"Ergun-Longmire B.","year":"2000","unstructured":"Ergun-Longmire B, Maclaren NK.","journal-title":"Etiology and Pathogenesis of Diabetes Mellitus IN Children"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc09-S062","volume":"32","author":"","year":"2009","unstructured":". Diagnosis and classification of diabetes mellitus.","journal-title":"Diabetes Care"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0031-3955(16)34604-1","volume":"31","author":"Lebovitz H.E.","year":"1984","unstructured":"Lebovitz HE. Etiology and pathogenesis of diabetes mellitus.","journal-title":"Pediatr Clin North Am"},{"key":"ref=9"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/pgmj.1.6.73","volume":"1","author":"Maclean H.","year":"1926","unstructured":"Maclean H. Some observations on diabetes and insulin in general practice.","journal-title":"Postgrad Med J"},{"key":"ref=11","first-page":"697","volume":"147","author":"","year":"1992","unstructured":". Clinical practice guidelines for treatment of diabetes mellitus.","journal-title":"CMAJ"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0140-6736(57)91023-1","volume":"272","author":"Butterfield W.J.","year":"1957","unstructured":"Butterfield WJ, Camp JL, Hardwick C, Holling HE. Clinical studies on the hypoglycaemic action of the sulphonylureas.","journal-title":"Lancet"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2337\/diab.7.6.468","volume":"7","author":"Krall L.P.","year":"1958","unstructured":"Krall LP, White P, Bradley RF. Clinical use of the biguanides and their role in stabilizing juvenile-type diabetes.","journal-title":"Diabetes"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12955-018-0883-1","volume":"16","author":"Weatherall J.","year":"2018","unstructured":"Weatherall J, Polonsky WH, Lanar S. When insulin degludec enhances quality of life in patients with type 2 diabetes: A qualitative investigation.","journal-title":"Health Qual Life Outcomes"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s13300-014-0076-9","volume":"5","author":"Vora J.","year":"2014","unstructured":"Vora J, Christensen T, Rana A, Bain SC. Insulin degludec versus insulin glargine in type 1 and type 2 diabetes mellitus: A meta-analysis of endpoints in phase 3a trials.","journal-title":"Diabetes Ther"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.2337\/dc10-1915","volume":"34","author":"Johnston S.S.","year":"2011","unstructured":"Johnston SS, Conner C, Aagren M, Smith DM, Bouchard J, Brett J. Evidence linking hypoglycemic events to an increased risk of acute cardiovascular events in patients with type 2 diabetes.","journal-title":"Diabetes Care"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1530\/EJE-17-0804","volume":"178","author":"Rys P.M.","year":"2018","unstructured":"Rys PM, Ludwig-Slomczynska AH, Cyganek K, Malecki MT. Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies.","journal-title":"Eur J Endocrinol"},{"key":"ref=18","first-page":"1","volume":"9","author":"Continuous S.I.I.","year":"2009","unstructured":"Continuous SII. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.","journal-title":"Ont Health Technol Assess Ser"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","volume":"383","author":"Atkinson M.A.","year":"2014","unstructured":"Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes.","journal-title":"Lancet"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.2042-7158.2011.01369.x","volume":"64","author":"Bariya S.H.","year":"2012","unstructured":"Bariya SH, Gohel MC, Mehta TA, Sharma OP. Microneedles: an emerging transdermal drug delivery system.","journal-title":"J Pharm Pharmacol"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/dia.2016.0156","volume":"18","author":"Kochba E.","year":"2016","unstructured":"Kochba E, Levin Y, Raz I, Cahn A. Improved Insulin Pharmacokinetics Using a Novel Microneedle Device for Intradermal Delivery in Patients with Type 2 Diabetes.","journal-title":"Diabetes Technol Ther"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/138161210790883778","volume":"16","author":"Campisi G.","year":"2010","unstructured":"Campisi G, Paderni C, Saccone R, Di Fede O, Wolff A, Giannola LI. Human buccal mucosa as an innovative site of drug delivery.","journal-title":"Curr Pharm Des"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jconrel.2014.05.060","volume":"190","author":"Kraan H.","year":"2014","unstructured":"Kraan H, Vrieling H, Czerkinsky C, Jiskoot W, Kersten G, Amorij JP. Buccal and sublingual vaccine delivery.","journal-title":"J Control Release"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.nut.2009.08.001","volume":"26","author":"Henkin R.I.","year":"2010","unstructured":"Henkin RI. Inhaled insulin-intrapulmonary, intranasal, and other routes of administration: mechanisms of action.","journal-title":"Nutrition"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"32498","DOI":"10.1038\/srep32498","volume":"6","author":"Iyire A.","year":"2016","unstructured":"Iyire A, Alaayedi M, Mohammed AR. Pre-formulation and systematic evaluation of amino acid assisted permeability of insulin across in vitro buccal cell layers.","journal-title":"Sci Rep"},{"key":"ref=26"},{"key":"ref=27","first-page":"15","volume":"1","author":"Shojaei A.H.","year":"1998","unstructured":"Shojaei AH. Buccal mucosa as a route for systemic drug delivery: a review.","journal-title":"J Pharm Pharm Sci"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1081\/DDC-120024178","volume":"29","author":"Hao J.","year":"2003","unstructured":"Hao J, Heng PW. Buccal delivery systems.","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-014-1485-1","volume":"32","author":"Caon T.","year":"2015","unstructured":"Caon T, Jin L, Sim\u00f5es CM, Norton RS, Nicolazzo JA. Enhancing the buccal mucosal delivery of peptide and protein therapeutics.","journal-title":"Pharm Res"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/jop.1989.5.81","volume":"5","author":"Chiou G.C.","year":"1989","unstructured":"Chiou GC, Chuang CY, Chang MS. Systemic delivery of insulin through eyes to lower the glucose concentration.","journal-title":"J Ocul Pharmacol"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/dia.2005.7.695","volume":"7","author":"Xuan B.","year":"2005","unstructured":"Xuan B, McClellan DA, Moore R, Chiou GC. Alternative delivery of insulin via eye drops.","journal-title":"Diabetes Technol Ther"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/CRD.0000000000000143","volume":"25","author":"Chan J.","year":"2017","unstructured":"Chan J, Cheng-Lai A. Inhaled insulin: A clinical and historical review.","journal-title":"Cardiol Rev"},{"key":"ref=33"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.clinthera.2014.06.025","volume":"36","author":"Santos Cavaiola T.","year":"2014","unstructured":"Santos Cavaiola T, Edelman S. Inhaled insulin: a breath of fresh air? A review of inhaled insulin.","journal-title":"Clin Ther"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/VHRM.S6098","volume":"6","author":"Mastrandrea L.D.","year":"2010","unstructured":"Mastrandrea LD. Inhaled insulin: overview of a novel route of insulin administration.","journal-title":"Vasc Health Risk Manag"},{"key":"ref=36","first-page":"1181","volume":"72","author":"Ledet G.","year":"2015","unstructured":"Ledet G, Graves RA, Bostanian LA, Mandal TK. A second-generation inhaled insulin for diabetes mellitus. American journal of health-system pharmacy.","journal-title":"AJHP"},{"key":"ref=37","volume":"3","author":"Li J.","year":"2002","unstructured":"Li J, Yang L, Ferguson SM. evaluation of dissolution behavior for a colon-specific drug delivery system (CODES) in multi-pH media using United States Pharmacopeia apparatus II and III.","journal-title":"AAPS PharmSciTech"},{"key":"ref=38"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0168-3659(98)00151-5","volume":"58","author":"Khan M.Z.","year":"1999","unstructured":"Khan MZ, Prebeg Z, Kurjakovi\u0107 N. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation of drug release using Eudragit L100-55 and Eudragit S100 combinations.","journal-title":"J Control Release"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/193229681300700228","volume":"7","author":"Fonte P.","year":"2013","unstructured":"Fonte P, Ara\u00fajo F, Reis S, Sarmento B. Oral insulin delivery: how far are we?","journal-title":"J Diabetes Sci Technol"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4155\/tde.12.164","volume":"4","author":"Kamei N.","year":"2013","unstructured":"Kamei N, Nielsen EJ, Khafagy S, Takeda-Morishita M. Noninvasive insulin delivery: the great potential of cell-penetrating peptides.","journal-title":"Ther Deliv"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1210\/jc.2017-01976","volume":"103","author":"Kullmann S.","year":"2018","unstructured":"Kullmann S, Veit R, Peter A. Dose-dependent effects of intranasal insulin on resting-state brain activity.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.npp.1301193","volume":"32","author":"Benedict C.","year":"2007","unstructured":"Benedict C, Hallschmid M, Schmitz K. Intranasal insulin improves memory in humans: superiority of insulin aspart.","journal-title":"Neuropsychopharmacology"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nn0602-849","volume":"5","author":"Born J.","year":"2002","unstructured":"Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL. Sniffing neuropeptides: a transnasal approach to the human brain.","journal-title":"Nat Neurosci"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4193\/Rhin15.065","volume":"53","author":"Sch\u00f6pf V.","year":"2015","unstructured":"Sch\u00f6pf V, Kollndorfer K, Pollak M, Mueller CA, Freiherr J. Intranasal insulin influences the olfactory performance of patients with smell loss, dependent on the body mass index: A pilot study.","journal-title":"Rhinology"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/dom.13279","volume":"20","author":"Schmid V.","year":"2018","unstructured":"Schmid V, Kullmann S, Gfr\u00f6rer W. Safety of intranasal human insulin: A review.","journal-title":"Diabetes Obes Metab"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/dom.13279","volume":"20","author":"Schmid V.","year":"2018","unstructured":"Schmid V, Kullmann S, Gfr\u00f6rer W. Safety of intranasal human insulin: A review.","journal-title":"Diabetes Obes Metab"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1461-5347(00)00296-0","volume":"3","author":"Vermani K.","year":"2000","unstructured":"Vermani K, Garg S. The scope and potential of vaginal drug delivery.","journal-title":"Pharm Sci Technol Today"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jconrel.2014.04.033","volume":"190","author":"Ensign L.M.","year":"2014","unstructured":"Ensign LM, Cone R, Hanes J. Nanoparticle-based drug delivery to the vagina: A review.","journal-title":"J Control Release"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/10717540590968891","volume":"12","author":"Ning M.","year":"2005","unstructured":"Ning M, Guo Y, Pan H, Yu H, Gu Z. Niosomes with sorbitan monoester as a carrier for vaginal delivery of insulin: studies in rats.","journal-title":"Drug Deliv"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-5173(99)00227-6","volume":"189","author":"Yun M.","year":"1999","unstructured":"Yun M, Choi H, Jung J, Kim C. Development of a thermo-reversible insulin liquid suppository with bioavailability enhancement.","journal-title":"Int J Pharm"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2337\/diacare.4.4.454","volume":"4","author":"Yamasaki Y.","year":"1981","unstructured":"Yamasaki Y, Shichiri M, Kawamori R. The effectiveness of rectal administration of insulin suppository on normal and diabetic subjects.","journal-title":"Diabetes Care"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1517\/17425247.2012.737779","volume":"9","author":"Soares S.","year":"2012","unstructured":"Soares S, Costa A, Sarmento B. Novel non-invasive methods of insulin delivery.","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/353737a0","volume":"353","author":"O\u2019Regan B.","year":"1991","unstructured":"O\u2019Regan B, Gr\u00e4tzel M. A low-cost, high-efficiency solar cell based on dye-sensitized colloidal TiO2 films.","journal-title":"Nature"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/cr00033a004","volume":"95","author":"Hoffmann M.R.","year":"1995","unstructured":"Hoffmann MR, Martin ST, Choi W, Bahnemann DW. Environmental Applications of Semiconductor Photocatalysis.","journal-title":"Chem Rev"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S1359-6446(03)02903-9","volume":"8","author":"Sahoo S.K.","year":"2003","unstructured":"Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging.","journal-title":"Drug Discov Today"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd1494","volume":"3","author":"Rabinow B.E.","year":"2004","unstructured":"Rabinow BE. Nanosuspensions in drug delivery.","journal-title":"Nat Rev Drug Discov"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.addr.2010.07.009","volume":"62","author":"Xie J.","year":"2010","unstructured":"Xie J, Lee S, Chen X. Nanoparticle-based theranostic agents.","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/wnan.1329","volume":"7","author":"DiSanto R.M.","year":"2015","unstructured":"DiSanto RM, Subramanian V, Gu Z. Recent advances in nanotechnology for diabetes treatment.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"10177","DOI":"10.1021\/cr500029g","volume":"114","author":"Rajh T.","year":"2014","unstructured":"Rajh T, Dimitrijevic NM, Bissonnette M, Koritarov T, Konda V. Titanium dioxide in the service of the biomedical revolution.","journal-title":"Chem Rev"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.colsurfb.2017.09.031","volume":"160","author":"Davidovi\u0107 S.","year":"2017","unstructured":"Davidovi\u0107 S, Lazi\u0107 V, Vukoje I. Dextran coated silver nanoparticles - Chemical sensor for selective cysteine detection.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1039\/B406727D","volume":"34","author":"de Las Heras Alarcon C.","year":"2005","unstructured":"de Las Heras Alarcon C, Pennadam S, Alexander C. Stimuli responsive polymers for biomedical applications.","journal-title":"Chem Soc Rev"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2006.08.013","volume":"116","author":"des Rieux A.","year":"2006","unstructured":"des Rieux A, Fievez V, Garinot M, Schneider YJ, Preat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.","journal-title":"J Control Release"},{"key":"ref=64","first-page":"351","volume":"23","author":"Alai M.S.","year":"2015","unstructured":"Alai MS, Lin WJ, Pingale SS. Application of polymeric nanoparticles and micelles in insulin oral delivery.","journal-title":"Yao Wu Shi Pin Fen Xi"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"9315","DOI":"10.1021\/acsami.8b00507","volume":"10","author":"Xu Y.","year":"2018","unstructured":"Xu Y, Zheng Y, Wu L, Zhu X, Zhang Z, Huang Y. Novel Solid Lipid Nanoparticle with Endosomal Escape Function for Oral Delivery of Insulin.","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5173(92)90348-6","volume":"78","author":"Morishita M.","year":"1992","unstructured":"Morishita M, Morishita I, Takayama K, Machida Y, Nagai T. Novel oral microspheres of insulin with protease inhibitor protecting from enzymatic degradation.","journal-title":"Int J Pharm"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2008.05.010","volume":"132","author":"Kratz F.","year":"2008","unstructured":"Kratz F. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.","journal-title":"J Control Release"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.addr.2008.09.001","volume":"60","author":"Liu Z.","year":"2008","unstructured":"Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z. Polysaccharides-based nanoparticles as drug delivery systems.","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","volume":"161","author":"Danhier F.","year":"2012","unstructured":"Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Preat V. PLGA-based nanoparticles: an overview of biomedical applications.","journal-title":"J Control Release"},{"key":"ref=70"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2015.02.055","volume":"484","author":"Yu F.","year":"2015","unstructured":"Yu F, Li Y, Liu CS. Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin.","journal-title":"Int J Pharm"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2017.09.003","volume":"264","author":"Wong C.Y.","year":"2017","unstructured":"Wong CY, Al-Salami H, Dass CR. Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment.","journal-title":"J Control Release"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cis.2018.02.002","volume":"253","author":"McClements D.J.","year":"2018","unstructured":"McClements DJ. Encapsulation, protection, and delivery of bioactive proteins and peptides using nanoparticle and microparticle systems: A review.","journal-title":"Adv Colloid Interface Sci"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2017.10.022","volume":"151","author":"Fan W.","year":"2018","unstructured":"Fan W, Xia D, Zhu Q. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery.","journal-title":"Biomaterials"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.diabres.2017.11.018","volume":"136","author":"Kesharwani P.","year":"2018","unstructured":"Kesharwani P, Gorain B, Low SY. Nanotechnology based approaches for anti-diabetic drugs delivery.","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijpharm.2017.12.036","volume":"537","author":"Wong C.Y.","year":"2018","unstructured":"Wong CY, Al-Salami H, Dass CR. Microparticles, microcapsules and microspheres: A review of recent developments and prospects for oral delivery of insulin.","journal-title":"Int J Pharm"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijpharm.2018.02.045","volume":"542","author":"Czuba E.","year":"2018","unstructured":"Czuba E, Diop M, Mura C. Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system.","journal-title":"Int J Pharm"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1021\/mp100253e","volume":"7","author":"Gao W.","year":"2010","unstructured":"Gao W, Chan JM, Farokhzad OC. pH-Responsive nanoparticles for drug delivery.","journal-title":"Mol Pharm"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/wnan.1389","volume":"8","author":"Karimi M.","year":"2016","unstructured":"Karimi M, Eslami M, Sahandi-Zangabad P. pH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1039\/C7NR08047F","volume":"10","author":"He Z.","year":"2018","unstructured":"He Z, Liu Z, Tian H. Scalable production of core-shell nanoparticles by flash nanocomplexation to enhance mucosal transport for oral delivery of insulin.","journal-title":"Nanoscale"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.addr.2008.08.002","volume":"60","author":"Hamidi M.","year":"2008","unstructured":"Hamidi M, Azadi A, Rafiei P. Hydrogel nanoparticles in drug delivery.","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.2147\/IJN.S144986","volume":"12","author":"Liao Z.X.","year":"2017","unstructured":"Liao ZX, Liu MC, Kempson IM, Fa YC, Huang KY. Light-triggered methylcellulose gold nanoparticle hydrogels for leptin release to inhibit fat stores in adipocytes.","journal-title":"Int J Nanomedicine"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/nbt1101-1013","volume":"19","author":"Mitchell P.","year":"2001","unstructured":"Mitchell P. Turning the spotlight on cellular imaging.","journal-title":"Nat Biotechnol"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1021\/ac990630n","volume":"71","author":"Clark H.A.","year":"1999","unstructured":"Clark HA, Kopelman R, Tjalkens R, Philbert MA. Optical nanosensors for chemical analysis inside single living cells. 2. Sensors for pH and calcium and the intracellular application of PEBBLE sensors.","journal-title":"Anal Chem"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.snb.2014.04.108","volume":"201","author":"Nikoli\u0107 M.G.","year":"2014","unstructured":"Nikoli\u0107 MG, Anti\u0107 \u017d, \u0106ulubrk S, Nedeljkovi\u0107 JM, Drami\u0107anin MD. Temperature sensing with Eu doped TiO nanoparticles.","journal-title":"Sens Actuators B Chem"},{"key":"ref=86"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.nano.2017.05.002","volume":"13","author":"Deng W.","year":"2017","unstructured":"Deng W, Xie Q, Wang H, Ma Z, Wu B, Zhang X. Selenium nanoparticles as versatile carriers for oral delivery of insulin: Insight into the synergic antidiabetic effect and mechanism.","journal-title":"Nanomedicine (Lond)"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.colsurfb.2017.04.032","volume":"155","author":"Baji\u0107 V.","year":"2017","unstructured":"Baji\u0107 V, Spremo-Potparevi\u0107 B, \u017divkovi\u0107 L. Surface-modified TiO nanoparticles with ascorbic acid: Antioxidant properties and efficiency against DNA damage in vitro.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.fct.2018.02.064","volume":"115","author":"Dekanski D.","year":"2018","unstructured":"Dekanski D, Spremo-Potparevic B, Bajic V. Acute toxicity study in mice of orally administrated TiO nanoparticles functionalized with caffeic acid.","journal-title":"Food Chem Toxicol"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1021\/nn9011187","volume":"4","author":"Lacerda S.H.","year":"2010","unstructured":"Lacerda SH, Park JJ, Meuse C. Interaction of gold nanoparticles with common human blood proteins.","journal-title":"ACS Nano"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s11095-007-9257-9","volume":"24","author":"Bhumkar D.R.","year":"2007","unstructured":"Bhumkar DR, Joshi HM, Sastry M, Pokharkar VB. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin.","journal-title":"Pharm Res"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jphotobiol.2017.06.028","volume":"173","author":"Anand K.","year":"2017","unstructured":"Anand K, Tiloke C, Naidoo P, Chuturgoon AA. Phytonanotherapy for management of diabetes using green synthesis nanoparticles.","journal-title":"J Photochem Photobiol B"},{"key":"ref=93"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.actbio.2015.12.017","volume":"31","author":"Verma A.","year":"2016","unstructured":"Verma A, Sharma S, Gupta PK. Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: A mucoadhesive and pH responsive carrier for improved oral delivery of insulin.","journal-title":"Acta Biomater"},{"key":"ref=95"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.nano.2017.11.012","volume":"14","author":"Zhang Y.","year":"2018","unstructured":"Zhang Y, Zhang L, Ban Q, Li J, Li CH, Guan YQ. Preparation and characterization of hydroxyapatite nanoparticles carrying insulin and gallic acid for insulin oral delivery.","journal-title":"Nanomedicine (Lond)"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/170494","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T18:02:37Z","timestamp":1606672957000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/170494\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,5,28]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612825666190306153838","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-02-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}